ACTRIMS-ECTRIMS Multiple Sclerosis Treatments and Developments in Diagnostics
Jeffrey Cohen, a Neurologist with the Cleveland Clinic, a renowned leader in Multiple Sclerosis research and the President of ACTRIMS, the world’s lar...
135 articles
Jeffrey Cohen, a Neurologist with the Cleveland Clinic, a renowned leader in Multiple Sclerosis research and the President of ACTRIMS, the world’s lar...
Andrew Blumenfeld, MD, director of the Headache Center of Southern California discusses the often misunderstood condition of migraine, how the disease i...
Nicholas, MD, MPH, discusses multiple sclerosis (MS) and MS relapses. She talks about the recently FDA approved ZEPOSIA® (ozanimod) a new oral therap...
James Wheless, MD, Co-Director of the Le Bonheur Comprehensive Epilepsy Program discusses how sleep deprivation due to stress and anxiety over the pande...
For Progressive Multiple Sclerosis Day 2020 patient Vickie Siculiano shares her journey living with primary progressive multiple sclerosis.
Returning guests, Christina Korines, a Parkinson's patient, and President and CEO of the Parkinson's Foundation John Lehr, discuss a new awareness campa...
Neurology Patient Value Unit at UCB, a global pharmaceutical company, discusses the collaboration with the University of Washington's School of Pharmacy...
Jerry Silver, Professor of Neurosciences at Case Western Reserve University’s School of Medicine and advisor to NervGen Pharma, discusses NervGen Phar...
Christi Heck discusses drug-resistant epilepsy and vagus nerve stimulation (VNS) therapy. Learn more on Health Professional Radio.
Regina Berkovich discusses Mayzent, the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS).